Dovitinib dilactic acid reduces tumor growth and tumor-induced bone changes in an experimental breast cancer bone growth model.

J Bone Oncol · 2019 · PMC6434100 · PMID 30956945

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

Although the differences did not reach statistical significance, [ 18 F]FDG/PET imaging revealed a trend in decreased metabolic active tumor volume and metabolic activity ([ 18 F]FDG uptake) in treated animals.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.